Table 2. Safety endpoints.

Data are presented as medians (interquartile range).

*p < 0.001 versus immediately after treatment

Adverse event	Immediately after treatment	six months
Subject-reported burning	1 (1−1)	0 (0−1)*
Subject-reported pain	1 (1−1)	0 (0−2)*
Investigator-reported edema	1 (1−1)	0 (0−1)*
Investigator-reported erythema	0 (0−1)	0 (0−0)*